Title Management of Impetigo Protocol in MIUs and WICs. Author s job title Professional Lead, Minor Injuries Unit Directorate

Similar documents
Title Protocol for Insect Bites Stings for Patients in MIUs and WICs

Title Protocol for the Management of Urinary Tract Infections for Adult Females and Children in MIUs and WICs

Title Protocol for the Management of Shoulder Injuries in MIUs and WICs

Title Protocol for the Management of Asthma in the Minor Injuries Units

Title Protocol for the Management of Asthma

Title Management of Knee Injuries Protocol in MIUs and WICs

Title Management of Ankle and Lower Limb Injuries Protocol in MIUs and WICs

Final Ben Leger (Clinician) and Chris Bowman (Clinical Director) May July 2018

Title Protocol for the Management of Urinary Tract Infections for Adult Females and Children (3 years and over) in MIUs

making a referral for breast imaging Standard Operating Procedure

Title Protocol for the management of suspected cauda equine syndrome & decompensating spinal stenosis at NDDH

Document Control Report

Managing Hyperglycaemia in Acute (Adult) Inpatients Requiring Enteral Feeding Guidelines

Developed By Name Signature Date

Title Patients receiving dabigatran requiring emergency reversal for surgery or treatment of haemorrhage Guidelines. Department.

patient group direction

Developed By Name Signature Date

After care following insertion of suprapubic catheter

Policy and Procedure for the Development, Approval and Implementation of Patient Group Directions in NHS Haringey Clinical Commissioning Group

Title Deactivation of Implantable Cardioverter Defibrillators (ICD) towards the end of life Guidelines

Case scenarios: Patient Group Directions

Title Use of Pre-Operative Tests for Elective Surgery Guideline. Department. Anaesthetics. Comment / Changes / Approval

Title Physiotouch Standard Operating Procedure

PATIENT GROUP DIRECTION PROCEDURE

Patient Group Direction (PGD)

Sickness and Illness Policy

Sickness and Illness Policy

Drug Allergy A Guide to Diagnosis and Management

Transition for Children and Young People (age 0-18 years) with Diabetes

Patient Group Directions (PGDs)

Venous Thromboembolism (VTE) Prevention and Treatment of VTE in Patients Admitted to Hospital

Clinician Responsible for Training and Review: Emergency Department Consultant

Patient Group Direction for Doxycycline (Tetracycline) Version: 01 Start Date: October 2015 Expiry Date: October 2018

Ratified by: Care and Clinical Policies Date: 17 th February 2016

1.1. This guideline applies to medical, nursing and pharmacy staff in the safe and appropriate prescription and administration of acamprosate.

Cellcept. Eye Clinic Tel:

NHS West Cheshire Clinical Commissioning Group does not fund the prescribing for dental conditions on FP10.

Expiry Date: September 2009 Template Version: Page 1 of 7

PATIENT GROUP DIRECTION (PGD) FOR THE SUPPLY OF DOXYCYCLINE 100MG TABLETS FOR THE FIRST-LINE TREATMENT OF CHLAMYDIA TRACHOMATIS INFECTION

ILLNESS AND EXCLUSION POLICY

Title The Prescription of Adult Inpatient Parenteral Nutrition (PN) Guideline. Author s job title Consultant Gastroenterologist Directorate Medicine

Methotrexate for inflammatory bowel disease: what you need to know

Upper Respiratory Infections PATIENT INFORMATION LEAFLET. Clinical Governance. Dr David Gilliland FY2

Advice for rheumatoid patients at risk of developing foot related problems

Deep Vein Thrombosis and Pulmonary Embolism: Risks, Prevention & Treatment

Document Details. Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml

patient group direction

Dislocation of the Patella Knee 1

patient group direction

You will receive a copy of all communications sent to your GP. Please let us know if you would prefer not to receive this.

Northumbria Healthcare NHS Foundation Trust. Your guide to discharge from the breast clinic. Issued by the Breast Team

Clinician Responsible for Training and Review: Emergency Department Consultant

Community Psychiatric Nurse. Consultant Psychiatrist, Substance Misuse Services

Document Details Patient Group Direction Hepatitis A vaccine (Havrix Monodose ) Trust Ref No Local Ref (optional) Main points the

SKIN CARE AND PREVENTION AND MANAGEMENT OF WORK RELATED DERMATITIS

Oral N-Acetyl CystieneTablets. Patient Information

PATIENT GROUP DIRECTION (PGD) FOR THE ADMINISTRATION OF ORAL DIAZEPAM TO WORKING AGE AND OLDER PEOPLE IN THE COMMUNITY

Patient Group Direction for SALBUTAMOL INHALER (Version 02) Valid From 1 October September 2019

Shingles Procedure. (IPC Policy Manual)

Appendix C. Aneurin Bevan Health Board. Smoke Free Environment Policy

Title Management of Fever and Neutropenia (Neutropenic Sepsis) in Paediatric Oncology Patients presenting to NDDH Guidelines. Author s job title

Patient Group Directions Policy

PATIENT GROUP DIRECTION

patient group direction

Document Details. Patient Group Direction

GG&C PGD ref no: 2016/1338 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

Title Management of Children and Young People with Newly Diagnosed Type 1 Diabetes Mellitus Guideline

Version Number: 5. Patient Group Direction drawn up by: Chief Pharmacist - Strategy. Group direction authorised by:

patient group direction

PACKAGE LEAFLET: INFORMATION FOR THE USER

PAEDIATRIC ACUTE CARE GUIDELINE. Impetigo. This document should be read in conjunction with this DISCLAIMER

NHS Circular: PCA(M)(2011)4 abcdefghijklmnopqrstu TREATMENT OF ERECTILE DYSFUNCTION: PATIENTS WITH SEVERE DISTRESS. Summary

Urinary Catheter Passport SAMPLE COPY. A guide to looking after a urinary catheter. (for service users and healthcare workers) 2nd Edition

Patient Group Direction for GLUCAGON (Version 02) Valid From 1 October September 2019

Some general information on hepatitis A infection is given at the end of this leaflet.

Low back pain and sciatica in over 16s NICE quality standard

Clinical Condition Indication:

This document expires on Patient Group Direction No. VI 11

Document Details. Patient Group Direction

PATIENT GROUP DIRECTIONS POLICY

SHARED CARE GUIDELINE FOR BUCCAL MIDAZOLAM FOR THE TREATMENT OF PROLONGED SEIZURES IN CHILDREN

Comment / Changes / Approval. Initial version for consultation

TRUST WIDE DOCUMENT DOCUMENT NUMBER: ELHT Version 1

patient group direction

1. and it is more than 12 hours until your next dose, take the missed dose and continue with your normal schedule

Group A Streptococcal Infection

Chronic Obstructive Pulmonary Disease. Information about medication and an Action Plan to use if your condition gets worse due to an infection

Patient Group Direction for the Supply of Nitrofurantoin MR 100mg capsules

SALBUTAMOL INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline

The Clatterbridge Cancer Centre. NHS Foundation Trust. Lymphoedema Advice. Rehabilitation and Support. A guide for patients and carers

Chief Dental Officer England: Advice on commercial practice of online registered dental practitioners selling patient group directions for NHS

MANAGEMENT OF SICK CHILDREN GUIDELINES

Chickenpox Procedure. (IPC Policy Manual)

BACTERIAL VAGINOSIS. Patient Information Leaflet. Your Health. Our Priority. Microbiology Pathology Department.

This document expires on Patient Group Direction No. VI 5

Initiation of Clozapine Treatment Community Patients

Denosumab for the treatment of osteoporosis in postmenopausal women at increased risk of fractures

Prescription only medicines (POMs)

Diphencyprone (DPC) treatment for Alopecia Areata

Transcription:

Document Control Title Management of Impetigo Protocol in MIUs and WICs Author Author s job title Professional Lead, Minor Injuries Unit Directorate Department MIU Version Date Issued Status Comment / Changes / Approval 1.0 Dec 2012 Final Published on BOB. Expires December 2015 2.0 May Final Approved by (Clinical Director) 2016 2.1 Feb 2017 Revision Amendment to protocol, age reference under section 1 Main Contact Tel: Direct Dial 01271 322480 North Devon District Hospital Raleigh Park Barnstaple, EX31 4JB Lead Director Medical Director Document Class Protocol Target Audience MIU / A&E Staff Distribution List Senior Management Distribution Method Trust s internal website Superseded Documents Management of Impetigo (over 2 years of age) Standard Operating Procedure v2.0 Issue Date May 2016 Review Date May 2019 Review Cycle Three years Consulted with the following stakeholders Contact responsible for implementation and ED Consultant monitoring compliance: Professional Lead, Minor Injuries Unit MIU Leads Antibiotic Pharmacist Education/ training will be provided by: Professional Lead, Minor Injuries Unit Approval and Review Process Lead Clinician for Local Archive Reference G:\Corporate Governance\Policies and Protocols Local Path MIU Filename Management of Impetigo Protocol V2.1 Feb17 Management of Impetigo Protocol v2.1 Feb17 Page 1 of 9

Policy categories for Trust s internal website (Bob) MIU, Tags for Trust s internal website (Bob) None Management of Impetigo Protocol v2.1 Feb17 Page 2 of 9

CONTENTS Document Control... 1 1. Purpose... 3 2. Presenting Symptoms... 3 3. History... 3 4. Referral... 4 5. Treatment... 4 6. Discharge Pathway... 5 7. References... 5 APPENDIX A Essential Documentation for All Patients Attending Unit or Centre... 7 APPENDIX B Essential Documentation for All Patients Attending Unit or Centre... 8 APPENDIX C Competency Form... 9 1. Purpose This protocol is for use by staff employed by Northern Devon Healthcare Trust who have achieved the agreed clinical competencies to work under the Flucloxacillin for widespread impetigo PGD and the Sodium Fusidate Cream for localised impetigo PGD. The protocol is for all patients in the Walk-In Centres and for patients over two years old in the MIUs. Any child under this age must be referred to a GP. 2. Presenting Symptoms Round spots with exudate and honey coloured crusts typically on the hands and face of a child, especially around the nose and mouth Prior to blisters breaking they appear as clusters of small round blisters or spots under the skin which then fill with clear fluid (vesicles) There is not usually pain or redness but an itchy sensation Often develops in an already damaged area of skin The patient may have lowered resistance following illness Common in children May develop due to close contact Common in warmer climate 3. History 3.1. Refer to History Taking and Clinical Documentation Protocol for Guidance (via policies website on Trust intranet) Look for Recent contact with known case of impetigo Duration of symptoms Management of Impetigo Protocol v2.1 Feb17 Page 3 of 9

Recent skin damage Recent illness Self-care measures 3.2. Clinical Examination Look for Site and distribution Colour Characteristics e.g. vesicles Blisters Honey crusts Feel Heat Tenderness Cervical / neck lymph glands if relevant to area, for swelling and tenderness Baseline observations including temperature and capillary refill time Record baseline observations including temperature and capillary refill time 4. Referral If rash does not resemble impetigo refer to medical practitioner. Any vesicles around the eyes are to be discussed with a medical practitioner. 5. Treatment Mild impetigo Severe impetigo Treat localised lesions with sodium fusidate cream 2% as PGD Advise of rigorous hand-washing / hygiene Use separate cloths and towels Avoid nursery / school / workplace until completion of 48 hours of antibiotic treatment Food handlers to avoid work for 1 week If no improvement with treatment patient should contact GP Widespread fever or swollen glands Swab lesions and send to Microbiology Department for microscopic culture and sensitivity Oral flucloxacillin as PGD Management of Impetigo Protocol v2.1 Feb17 Page 4 of 9

Refer penicillin allergic patients to medical practitioner or non-medical prescriber Follow treatment guidance as for mild impetigo All females taking oral contraception should be advised to use extra precautions if taking antibiotics 6. Discharge Pathway DOCUMENTATION TO BE COMPLETED - Clinical treatment record as per Documentation and record keeping policies. - Copy of clinical treatment record to General Practitioner; to be sent to surgery as per Record keeping policy. - For patients being transferred to secondary care, ensure a copy of the clinical treatment record is sent with patient. A copy will also be sent to surgery in the normal manner. - For patients seeing their General Practitioner in next 24 hours ensure patient is given a copy of the clinical treatment record to take with them. A copy will also be sent to surgery in the normal manner. BEFORE DISCHARGE ENSURE: - Those patients who have been referred for further acute intervention has appropriate transport to meet their needs, all relevant treatment has been prescribed and administered and correct information and documentation is given to the patient. - The patient understands that if condition deteriorates or they have further concerns they should seek further advice. - The patient demonstrates understanding of advice given during consultation. - The patient has been provided with written advice leaflet to re-enforce advice given during consultation. - The patient demonstrates an understanding of how to manage subsequent problems. 7. References British National Formulary online via https://www.medicinescomplete.com/mc/ British National Formulary for Children https://www.medicinescomplete.com/mc/ Clinical knowledge Summaries (http://cks.nice.org.uk/#?char=a) July 2013 Management of Impetigo Protocol v2.1 Feb17 Page 5 of 9

North and East Devon Formulary online (accessed March 2016) Patient Group Direction 9.06 version 6.0: Administration / Supply of Flucloxacillin by Registered Practitioners employed by Northern Devon Healthcare Trust Patient Group Direction 9.15 version 1.0: Supply of Sodium Fusidate 2% Cream by Registered Practitioners employed by Northern Devon Healthcare Trust, Torbay and Southern Devon Health and Care NHS Trust Management of Impetigo Protocol v2.1 Feb17 Page 6 of 9

APPENDIX A Essential Documentation for All Patients Attending Unit or Centre Adults Consent Gain consent to be seen by a nurse practitioner Gain consent for treatment and sharing information Clinical Presentation If unwell assess for: - Airway - Breathing - Circulation - Disability - Exposure Document a full set of observations including neurological observations including Glasgow coma score if applicable. Record EWS: if 7 or above arrange immediate transfer to secondary care. Document pain score using numeric rating scale. For cognitively impaired patients document any signs of pain (e.g. grimaces or distress). Safeguarding - Assess for mental capacity and if person is a vulnerable adult. - Assess for learning disability and whether patient has a hospital passport in place. - Assess for risk of domestic abuse. - Assess falls risk. Complete falls referral if applicable. - Document names of persons accompanying patient. Management of Impetigo Protocol v2.1 Feb17 Page 7 of 9

APPENDIX B Essential Documentation for All Patients Attending Unit or Centre Child and Young Persons under 18 Years Old Consent Gain consent to be seen by a nurse practitioner Gain consent for treatment and sharing information Assess and document Gillick competency according to Fraser guideline if applicable. Document the name of persons accompanying patient. Clinical Presentation If unwell assess for: - Airway - Breathing - Circulation - Disability - Exposure Record PEWS: if any one parameter is triggered transfer to secondary care or seek advice from medical practitioner. Use guideline Traffic Light System (NICE) 2013 if applicable. Use guideline Feverish Illness (NICE) 2013 if applicable. Document pain score using FLACC, Wong Baker Faces or numeric rating scale. Safeguarding - Assess safeguarding - Assess for domestic abuse in the home - Assess for learning disability DOCUMENT ALL FINDINGS IN THE CLINICAL TREATMENT RECORD AND ACT ON THEM FOLLOWING NDHCT GUIDELINES. Management of Impetigo Protocol v2.1 Feb17 Page 8 of 9

APPENDIX C Competency Form Management of Impetigo Protocol operational from May 2016 and expires end of May 2019 The registered health professional named below, being employees of Northern Devon Healthcare Trust based at. have received training and are competent to operate under this protocol NAME (please print) PROFESSIONAL TITLE SIGNATURE AUTHORISING MANAGER (please print) MANAGER S SIGNATURE DATE Keep original with the authorising manager and send a copy to:, Northern Devon Healthcare Trust NHS, Raleigh Park, Barnstaple, Devon EX31 4JB Management of Impetigo Protocol v2.1 Feb17 Page 9 of 9